Related Experiment Video

Updated: May 6, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.1K

Underrepresentation of atopic dermatitis publications in pediatric journals: a bibliometric analysis

Barak Zlakishvili1, Sarah Weissmann2,3, Amir Horev2,4

  • 1Hebrew University School of Medicine, Jerusalem.

Dermatology Reports
|December 13, 2024
PubMed

Insights

This bibliometric analysis reveals underrepresentation of atopic dermatitis (AD) research in pediatric literature. This may affect clinical care and societal costs for AD patients.

Area of Science:

  • Bibliometrics
  • Dermatology
  • Pediatrics

Background:

  • Atopic dermatitis (AD) is a common pediatric skin condition.
  • Extensive research exists on AD, but pediatric representation is unclear.

Purpose of the Study:

  • To assess the pediatric representation in the most cited atopic dermatitis literature.
  • To identify potential impacts on clinical care and societal costs.

Main Methods:

  • Bibliometric analysis of publications with "atopic" and "dermatitis" or "eczema" in the title.
  • Data sourced from the Web of Science citation indexing database.
  • Articles ranked by Annual Citation (AC) and impact factor.

Main Results:

  • 28,360 publications were retrieved.
  • Dermatology literature showed significantly higher citation and usage metrics compared to general medicine and pediatrics.
  • A notable underrepresentation of AD publications was found in pediatric literature.

Conclusions:

  • This study highlights the underrepresentation of atopic dermatitis research in pediatric literature.
  • This disparity may negatively impact clinical care for pediatric AD patients.
  • Underrepresentation could also affect the annual societal expenditure related to atopic dermatitis.

Keywords:
atopic dermatitisbibliometric analysisdermatologyeczemapediatrics

More Related Videos

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

3.3K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

753

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
26.7K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
417
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414